Replies to post #75928 on Innovation Pharmaceuticals Inc (IPIX)

[med5078]

I like that they have left the nod to Dr Frei on the advisory board. Seeing him put his name behind the company is one of the things that made me originally invest way back at 0.50. Dr Frei would not put his name behind junk science that is for sure. A man of his expertise and knowledge being excited about Kevetrin...you better believe he saw something good.

[John B]

Sox, good observation on the website. I believe we are much closer to Uplisting than most folks here think. Some posts here yesterday I believe clarified that we can uplist before having the shareholder meeting to elect additional independent directors. Also, now that SP is over $3 we no longer have to meet the Shareholders' equity requirement of $4 million, if we uplist for NYSE-MKT (standard 4). Which means we do not have to wait for partnership or have Leo raise additional cash via Aspire for this.
So all systems are GO on uplisting. In the Sept 2 PR it said "Cellceutix is focused on meeting the remaining requirements necessary to uplist to a senior exchange." One thing I have learned in the last 2 years is that when this management team says they are "focused" on something, they get it done!
I would not be surprised to see an uplisting PR in the coming days.
I disagree with others here that we should wait to qualify for Nasdaq. This would be months away. For one, we would need to trade above $4 for 60 straight days.
Some have mentioned the additional cost (yearly exchange fees) of uplisting as a negative. Realize though that if uplisting even caused the SP to go up $1, that CTIX would get 1 million dollars more when issuing a million shares to Aspire. I think uplisting is well worth the cost.